Renal safety and urate-lowering efficacy of febuxostat in gout patients with stage 4–5 chronic kidney disease not yet on dialysis

BACKGROUND/AIMS: The safety and efficacy of febuxostat in patients with stage 4–5 chronic kidney disease (CKD) are still unclear owing to a lack of studies in these patients. Therefore, we aimed to evaluate the effect of febuxostat on renal function, general safety, and efficacy in gout patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sang-Hyon, Lee, So-Yeon, Kim, Ji-Min, Son, Chang-Nam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373967/
https://www.ncbi.nlm.nih.gov/pubmed/30959584
http://dx.doi.org/10.3904/kjim.2018.423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373967/
https://www.ncbi.nlm.nih.gov/pubmed/30959584
http://dx.doi.org/10.3904/kjim.2018.423

Ejemplares similares